Detalles de la búsqueda
1.
Population pharmacokinetics and Bayesian estimation of mycophenolate mofetil in patients with autoimmune hepatitis.
Br J Clin Pharmacol
; 88(11): 4732-4741, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35514220
2.
The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol
; 27(3): 942-51, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26150605
3.
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon Ribavirin.
Ther Drug Monit
; 38(6): 684-692, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27559840
4.
Validation of the psychometrics properties of a French quality of life questionnaire among a cohort of renal transplant recipients less than one year.
Qual Life Res
; 25(9): 2347-59, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27016945
5.
eGFR decrease during antiviral C therapy with first generation protease inhibitors: a clinical significance?
Liver Int
; 35(1): 71-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25039814
6.
Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients.
Pharmacogenet Genomics
; 22(10): 725-32, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22863900
7.
Post-transplant lymphoproliferative disease (PTLD): Pharmacological, virological and other determinants.
Pharmacol Res
; 63(1): 1-7, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21056103
8.
Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.
Pharmacol Res
; 63(5): 432-8, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21241803
9.
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
Br J Clin Pharmacol
; 71(3): 391-402, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21284698
10.
Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients.
Ther Drug Monit
; 33(3): 285-94, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21516060
11.
Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Ther Drug Monit
; 33(2): 171-7, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21383655
12.
Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation.
Transplantation
; 105(7): 1585-1594, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32639405
13.
Polymorphisms in type I and II inosine monophosphate dehydrogenase genes and association with clinical outcome in patients on mycophenolate mofetil.
Pharmacogenet Genomics
; 20(9): 537-43, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20679962
14.
Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.
Br J Clin Pharmacol
; 69(6): 675-83, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20565459
15.
Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
Ther Drug Monit
; 32(2): 129-35, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20110850
16.
Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions.
Ther Drug Monit
; 32(2): 237-41, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20216114
17.
Adherence profiles in kidney transplant patients: Causes and consequences.
Patient Educ Couns
; 103(1): 189-198, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31447197
18.
Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.
Hepatology
; 47(5): 1453-61, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18435468
19.
A Prognostic Tool for Individualized Prediction of Graft Failure Risk within Ten Years after Kidney Transplantation.
J Transplant
; 2019: 7245142, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31093367
20.
An adjustable predictive score of graft survival in kidney transplant patients and the levels of risk linked to de novo donor-specific anti-HLA antibodies.
PLoS One
; 12(7): e0180236, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28671951